Safety and efficacy of AAE 581 in postmenopausal women with osteoporosis.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2013
At a glance
- Drugs Balicatib (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 07 May 2012 Actual end date (September 2005) added as reported by ClinicalTrials.gov.
- 07 May 2012 Actual patient number (676) added as reported by ClinicalTrials.gov.
- 03 Oct 2005 New trial record.